How Valves Play a Key Role in Fire Protection

On this episode of The Valve Chronicles, a podcast from Cla-Val, host Tyler Kern and Cla-Val’s Kyle Chism dove into perhaps the ultimate example of solutions that are often invisible, but always essential – fire protection products.

Chism serves as Cla-Val’s Fire Products Manager and, over nearly a decade at the company, he’s become intimately familiar with best practices for fire protection.

Fire protection valves, Chism said, are actually very simple.

“Every single one of our [waterworks] valves changes,” he said. “In fire protection, you’re going to have relief valves. You’re going to have reducing valves. You’re going to have pump suction control valves, air and vacuum valves, typical air release valves. You’re going to find most of those around pump skids and distributed throughout buildings.”

These valves also have important applications in offshore operations, which is something Chism has become experienced in dealing with thanks to work in the Houston region.

While the market, itself may be simple, it’s one that every industry needs to have. Because of that critical nature, Chism warned against some common missteps in implementing fire protection solutions, such as overthinking complex plans, “undersizing” valves to meet late-project budget restrictions and more.

To learn more, listen to the entire episode for more key insights.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More